{"ticker": {"uuid": "df9e824c-7b37-458f-8b21-b4916aa5edb4", "symbol": "009420", "name": "Hanall Biopharma Co., Ltd.", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Daewoong takes over Turn Bio\u2019s longevity platform from Hanall", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxORnBEelYyNVhONFpDRTVMQUZPczNmRkpHZjRDaEVmYkNFb3NEZy11a1dnYlVTN0VEbVVUQzVWQ20tMll4THR5UXN1dnRKMlFyaml4YU4zb3UzN0N3eDNwM2p0QVlTQzhrSjRpUjY0ZjFIQkNKWVlJOWtaU2dKbF9wbmJEY2p5U2lQS3NJSHdxTXdKVFZKQTlTMUVVWFljbFc5dGFN?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxPaUs5bE9XVFNHLWh6OVVxbXE5TGVOTjcxOTdYVkZyX1BkTThEQ3dfTm82a0pkYWpDbXJiRF9BLXhSTzB6VjlTZkNjdnlHUGFhdmg0bk9MdTZ5RFZ5dmpiQjM5TjZhaTFPOEEtZWo2Mjk2N05HMW5pVzN2TG1lX0FBUGctcXZnaDQtN0FiMzZWMkx1U0YzalBCVmlEUW8xY2puak5wMjE0bEN0SVJ3Rlc0NGhsb0s5UFBONEpBaXhzMFp2cmpPcFh3RXVSVXdiM0p6Uk8wOGNSVkJ2X0M3cWlCS2NnT3k4UlBuUlF2c3VkclpZRzRMRnNxME1jc0w0RDlmOFdnejNfQ00?oc=5", "source_name": "PR Newswire", "published_at": "2024-05-28T07:00:00+00:00", "published_display": "28 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson's Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxQVzlETFE3c09vdjJMSlJxRmsyZlhUd3Y5aWJwcThUT2VLMjZEVkZIMEFXRGRZblFzaGltM2NlX1MtcXd0OHR5bWtmcDJ5X0YwcU84dkFIVFBhWEdNVVI0ZDlYQjZScjRPRzIzcWc0QTJhZ0lldS1QaWowaFN2TUU0aTl6Q2RERnE2STIwNHlwckxfQWJVWk1WZTFwNlNab1h4QzBYSlZDcE5ITGlrSUxJclFhTWRCVURSWF9ZOHBHcmQ4ek9tdklzM0RnVVJBdHNZSzFpNnVLeWtfeHZZMWJNeVhjNUZrRUVWcnNpV3VDVkcyWHAwT1IwcGdQMk9QOHhHZ3FpVGZCclpCNE1FX0szRTJpeTFKdw?oc=5", "source_name": "PR Newswire", "published_at": "2023-06-12T07:00:00+00:00", "published_display": "12 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwJBVV95cUxPZ1BSeHVNVThwMFljUVlZVXJhT2ctcXhONkxqa0tkc3AwSjExNU1CaW1Ud1VVbGxScFdxTF84SHNuUDJkSmIwYktwX0pfR0J1RnpmZTU2Z3paeVl0ZV9kNlV5X19VYnR1MU1kS3BYMXg2MVA4bEhuT3hSLXVWLTdJbkxtandJWTVkaExPQUQ0RmZpM0p6ajdCYUM0Q05BUHI0NVM1cUd2bW1ldzA1SGtlcVIyenUzcFVsclQxc3V5RlVBV2VDS2hnZ2k5SWc3R1VjVkRUS0hyRzRiNFlYeFFJLUdLd0UxMHlYc3J6azNCTEhtUU1vd3JwdEZSTWdyS2ZwbjBkdTVtbkxycXQwZXRYWHBPc3BFOE5HZlA3OFJhOS1BUl9PUW91eW5YMEtFNFE?oc=5", "source_name": "PR Newswire", "published_at": "2023-05-25T07:00:00+00:00", "published_display": "25 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQQk0xVE54ZTNFT3BJUFdhQ1RQdlN3dWdvSVd1UlFDUnVrQVpjSFFBcVhnZExjVTk2LVI0WmRDYWZhelpFMk1uQ3oxRzNhNHdZa1VyWkZHRnUwaW10alg4VjZLbnlWY0VEWGE4ZHI4R1R4WHVoQWRweUNwOGpId1hPZTEtSENablE0M1JyanFMM0tCNi1IcHo4dnpHTUJYU2tubERWOHRhcnpWWjhpVXdZeUJKYUJGb1JrYmdxbVZpT3IxT3dEUFE?oc=5", "source_name": "PR Newswire", "published_at": "2023-02-10T08:00:00+00:00", "published_display": "10 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Daewoong takes over Turn Bio\u2019s longevity platform from Hanall", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxORnBEelYyNVhONFpDRTVMQUZPczNmRkpHZjRDaEVmYkNFb3NEZy11a1dnYlVTN0VEbVVUQzVWQ20tMll4THR5UXN1dnRKMlFyaml4YU4zb3UzN0N3eDNwM2p0QVlTQzhrSjRpUjY0ZjFIQkNKWVlJOWtaU2dKbF9wbmJEY2p5U2lQS3NJSHdxTXdKVFZKQTlTMUVVWFljbFc5dGFN?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxPaUs5bE9XVFNHLWh6OVVxbXE5TGVOTjcxOTdYVkZyX1BkTThEQ3dfTm82a0pkYWpDbXJiRF9BLXhSTzB6VjlTZkNjdnlHUGFhdmg0bk9MdTZ5RFZ5dmpiQjM5TjZhaTFPOEEtZWo2Mjk2N05HMW5pVzN2TG1lX0FBUGctcXZnaDQtN0FiMzZWMkx1U0YzalBCVmlEUW8xY2puak5wMjE0bEN0SVJ3Rlc0NGhsb0s5UFBONEpBaXhzMFp2cmpPcFh3RXVSVXdiM0p6Uk8wOGNSVkJ2X0M3cWlCS2NnT3k4UlBuUlF2c3VkclpZRzRMRnNxME1jc0w0RDlmOFdnejNfQ00?oc=5", "source_name": "PR Newswire", "published_at": "2024-05-28T07:00:00+00:00", "published_display": "28 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson's Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxQVzlETFE3c09vdjJMSlJxRmsyZlhUd3Y5aWJwcThUT2VLMjZEVkZIMEFXRGRZblFzaGltM2NlX1MtcXd0OHR5bWtmcDJ5X0YwcU84dkFIVFBhWEdNVVI0ZDlYQjZScjRPRzIzcWc0QTJhZ0lldS1QaWowaFN2TUU0aTl6Q2RERnE2STIwNHlwckxfQWJVWk1WZTFwNlNab1h4QzBYSlZDcE5ITGlrSUxJclFhTWRCVURSWF9ZOHBHcmQ4ek9tdklzM0RnVVJBdHNZSzFpNnVLeWtfeHZZMWJNeVhjNUZrRUVWcnNpV3VDVkcyWHAwT1IwcGdQMk9QOHhHZ3FpVGZCclpCNE1FX0szRTJpeTFKdw?oc=5", "source_name": "PR Newswire", "published_at": "2023-06-12T07:00:00+00:00", "published_display": "12 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwJBVV95cUxPZ1BSeHVNVThwMFljUVlZVXJhT2ctcXhONkxqa0tkc3AwSjExNU1CaW1Ud1VVbGxScFdxTF84SHNuUDJkSmIwYktwX0pfR0J1RnpmZTU2Z3paeVl0ZV9kNlV5X19VYnR1MU1kS3BYMXg2MVA4bEhuT3hSLXVWLTdJbkxtandJWTVkaExPQUQ0RmZpM0p6ajdCYUM0Q05BUHI0NVM1cUd2bW1ldzA1SGtlcVIyenUzcFVsclQxc3V5RlVBV2VDS2hnZ2k5SWc3R1VjVkRUS0hyRzRiNFlYeFFJLUdLd0UxMHlYc3J6azNCTEhtUU1vd3JwdEZSTWdyS2ZwbjBkdTVtbkxycXQwZXRYWHBPc3BFOE5HZlA3OFJhOS1BUl9PUW91eW5YMEtFNFE?oc=5", "source_name": "PR Newswire", "published_at": "2023-05-25T07:00:00+00:00", "published_display": "25 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQQk0xVE54ZTNFT3BJUFdhQ1RQdlN3dWdvSVd1UlFDUnVrQVpjSFFBcVhnZExjVTk2LVI0WmRDYWZhelpFMk1uQ3oxRzNhNHdZa1VyWkZHRnUwaW10alg4VjZLbnlWY0VEWGE4ZHI4R1R4WHVoQWRweUNwOGpId1hPZTEtSENablE0M1JyanFMM0tCNi1IcHo4dnpHTUJYU2tubERWOHRhcnpWWjhpVXdZeUJKYUJGb1JrYmdxbVZpT3IxT3dEUFE?oc=5", "source_name": "PR Newswire", "published_at": "2023-02-10T08:00:00+00:00", "published_display": "10 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 31, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 50800.0, "latest_week": "2026-06-19", "one_week_move": -1.4, "four_week_move": -10.9, "twelve_week_move": -21.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.242736, "market_dynamics_buy_signal": false, "relative_strength": -39.139973, "fair_value_gap": 38.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.4427, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.4% over one week, -10.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 4}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.4% over one week, -10.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Daewoong takes over Turn Bio\u2019s longevity platform from Hanall"}], "updated_at": "2026-06-22T18:10:04.737505+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}